Conmed (CNMD) Net Margin (2010 - 2026)

Conmed (CNMD) has reported Net Margin for 17 consecutive years, with 6.72% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Margin rose 46.0% year-over-year to 6.72%; the trailing twelve-month figure through Jun 2026 stood at 4.12% (down 419.0% YoY), and the FY2025 full-year result was 3.42%, down 671.0% from the prior year.
• Net Margin improved to 6.72% in Q2 2026 per CNMD's latest filing, from 4.36% in the prior quarter.
• Across five years, Net Margin topped out at 16.78% in Q3 2022 and bottomed at 60.71% in Q2 2022.
• Historically, Net Margin has averaged 3.23% across 5 years, with a median of 6.22% in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Margin slumped 6592 bps in 2022, then surged 6504 bps in 2023.
• Over 5 years, Net Margin stood at 10.6% in 2022, then fell by 5 bps to 10.11% in 2023, then fell by 4 bps to 9.76% in 2024, then plunged by 54 bps to 4.49% in 2025, then soared by 50 bps to 6.72% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 6.72%, 4.36%, and 4.49% for Q2 2026, Q1 2026, and Q4 2025 respectively.